Aging Clinical Trials

A listing of Aging medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 2140 clinical trials
My-Program & New& Test  

My-Program & New& Test

  • 0 views
  • 25 Apr, 2025
  • 0 views
  • 30 Oct, 2024
  • 0 views
  • 11 Apr, 2025
Program-P1  

Test Program-01

  • 0 views
  • 17 Nov, 2025
Featured trial
Virtual Trial 04  

test comment here.

Accepts healthy volunteers
Online studies
  • 0 views
  • 14 Mar, 2022
  • 1 location
  • Online study
Featured trial
Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)  

The Swiss-Ped-IBrainD is a national patient registry that collects information on diagnosis, symptoms, treatment, and follow-up of pediatric patients with an inflammatory brain disease in Switzerland. It was first implemented in 2020 in the pediatric clinic of the university hospital in Bern. Further centers all over Switzerland were opened for …

multiple sclerosis
neuromyelitis optica
myelitis
Online studies
optic neuritis
  • 0 views
  • 14 Mar, 2022
  • 1 location
  • Online study
Featured trial
A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine  

The reason for this 12-month, open-label study is to see if the study drug lasmiditan is safe and effective for the intermittent acute treatment of migraine in children aged 6 to 17. The study will last about 12 months and may include up to 7 visits.

ly573144
lasmiditan
migraine
acute treatment
migraine in children
  • 0 views
  • 16 Feb, 2024
  • 165 locations
Featured trial
AutoRun1197  

AutomationRun1197

  • 0 views
  • 01 May, 2023
  • 9 locations
Featured trial
A Phase I Trial of Intranasal Peptide T: Safety, Toxicity, and Pharmacokinetics in Human Immunodeficiency Virus-1 (HIV-1) Infected Patients.  

To study the safety and toxicity of intranasal peptide T (D-Ala-1-peptide-T-amide) in humans, and to find out how quickly and how much of a given dose enters the bloodstream and how quickly it leaves the bloodstream. To obtain information on the ability of intranasal peptide T to prevent, halt, and/or …

  • 0 views
  • 16 Jul, 2025
  • 3 locations